These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 9084574)

  • 21. Comparative effects of nabumetone, sulindac, and indomethacin on urinary prostaglandin excretion and platelet function in volunteers.
    Freed MI; Audet PR; Zariffa N; Krishna GG; Ilson BE; Everitt DE; Brown LE; Rizzo SM; Nichols AI; Jorkasky DK
    J Clin Pharmacol; 1994 Nov; 34(11):1098-108. PubMed ID: 7876402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogs.
    Kay-Mugford P; Benn SJ; LaMarre J; Conlon P
    Am J Vet Res; 2000 Jul; 61(7):802-10. PubMed ID: 10895904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of firocoxib, meloxicam, and tepoxalin administration on eicosanoid production in target tissues of healthy cats.
    Goodman LA; Torres BT; Reynolds LR; Budsberg SC
    Am J Vet Res; 2010 Sep; 71(9):1067-73. PubMed ID: 20807147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam.
    Weber EW; Slappendel R; Durieux ME; Dirksen R; van der Heide H; Spruit M
    Eur J Anaesthesiol; 2003 Dec; 20(12):963-6. PubMed ID: 14690098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of meloxicam, compared with other NSAIDs, on cartilage proteoglycan metabolism, synovial prostaglandin E2, and production of interleukins 1, 6 and 8, in human and porcine explants in organ culture.
    Rainsford KD; Ying C; Smith FC
    J Pharm Pharmacol; 1997 Oct; 49(10):991-8. PubMed ID: 9364409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and ex vivo inhibition of canine cyclooxygenase isoforms by robenacoxib: a comparative study.
    King JN; Rudaz C; Borer L; Jung M; Seewald W; Lees P
    Res Vet Sci; 2010 Jun; 88(3):497-506. PubMed ID: 20004922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meloxicam: influence on arachidonic acid metabolism. Part 1. In vitro findings.
    Engelhardt G; Bögel R; Schnitzer C; Utzmann R
    Biochem Pharmacol; 1996 Jan; 51(1):21-8. PubMed ID: 8534264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flurbiprofen and enantiomers in ophthalmic solution tested as inhibitors of prostanoid synthesis in human blood.
    van Haeringen NJ; van Sorge AA; Van Delft JL; Carballosa Coré-Bodelier VM
    J Ocul Pharmacol Ther; 2000 Aug; 16(4):345-52. PubMed ID: 10977130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.
    McAdam BF; Catella-Lawson F; Mardini IA; Kapoor S; Lawson JA; FitzGerald GA
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):272-7. PubMed ID: 9874808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of selective vs. non-selective cyclo-oxygenase inhibitors on fetal membrane prostaglandin synthesis.
    Sawdy R; Pan H; Sullivan M; Bennett P
    J Obstet Gynaecol; 2003 May; 23(3):239-43. PubMed ID: 12850850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis.
    Knijff-Dutmer EA; Kalsbeek-Batenburg EM; Koerts J; van de Laar MA
    Rheumatology (Oxford); 2002 Apr; 41(4):458-61. PubMed ID: 11961179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of non-steroidal anti-inflammatory compounds on human myometrial contractility.
    Sawdy RJ; Sullivan MH; Bennett PR
    Eur J Obstet Gynecol Reprod Biol; 2003 Jul; 109(1):33-40. PubMed ID: 12818440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of inhibitory effects of meloxicam and diclofenac on human thromboxane biosynthesis after single doses and at steady state.
    Tegeder I; Lötsch J; Krebs S; Muth-Selbach U; Brune K; Geisslinger G
    Clin Pharmacol Ther; 1999 May; 65(5):533-44. PubMed ID: 10340919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer.
    Murphey LJ; Williams MK; Sanchez SC; Byrne LM; Csiki I; Oates JA; Johnson DH; Morrow JD
    Anal Biochem; 2004 Nov; 334(2):266-75. PubMed ID: 15494133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tocolytic effect of the cyclooxygenase-2 inhibitor, meloxicam: studies on uterine contractions in the rat.
    Yousif MH; Thulesius O
    J Pharm Pharmacol; 1998 Jun; 50(6):681-5. PubMed ID: 9680081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclooxygenase-2 inhibition and experimental colitis: beneficial effects of phosphorothioated antisense oligonucleotide and meloxicam.
    Khan I; Al-Awadi FM; Thomas N; Haridas S; Anim JT
    Scand J Gastroenterol; 2002 Dec; 37(12):1428-36. PubMed ID: 12523593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.
    Beretta C; Garavaglia G; Cavalli M
    Pharmacol Res; 2005 Oct; 52(4):302-6. PubMed ID: 15939622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of in vitro assays for the evaluation of cyclooxygenase inhibitors and predicting selectivity of nonsteroidal anti-inflammatory drugs in cats.
    Giraudel JM; Toutain PL; Lees P
    Am J Vet Res; 2005 Apr; 66(4):700-9. PubMed ID: 15900953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.